Skip to main content
Top
Published in:

16-01-2024 | Glioma | Research

Immunotherapy with autologous dendritic cells in the complex treatment of malignant gliomas - results

Authors: Artemii Yuryevich Rynda, Dmitrii M. Rostovthev, Yulia M. Zabrodskaya, Victor E. Olyushin

Published in: Journal of Neuro-Oncology | Issue 2/2024

Login to get access

Abstract

Annotation

Malignant gliomas are the most common primary brain tumor. Despite the variety of modern treatments, it is still a fatal disease with an extremely poor prognosis. The use of immunotherapy as a technique for the treatment of malignant tumors has great promise, retraining and exploiting the patient’s immune response against tumors.

Objective

Evaluation of the effectiveness of dendritic cell vaccine in patients with malignant brain gliomas in the structure of complex treatment in comparison with the control group of patients without immunotherapy in the structure of treatment.

Materials and methods

In a single-center, prospective, cohort study, taking place on the basis of the RNSI named after prof. A.L. Polenov, 91 patients with morphologically established malignant glial tumor (glioblastoma) took part. The main group of 41 patients who, in addition to standard treatment (surgical, radiation and chemotherapy), underwent specific antitumor immunotherapy. 50 patients received only standard treatment, without immunotherapy.

Results

Median survival was 21.7 months in the immunotherapy group (95% CI 4–37 months) and 15.8 months (95% CI 3–22 months) in the non-immunotherapy group (p = 0.002). The median relapse-free period in the group with immunotherapy was 13.8 months (95% CI 1–20 months), and in the group without immunotherapy 7.9 months (95% CI 1–12 months) (p = 0.003).

Conclusion

In general, the use of immunotherapy in the structure of complex treatment of patients with malignant gliomas demonstrates a clear positive trend in terms of overall survival and median relapse-free period. But nevertheless, immunotherapy requires further development as a therapeutic tool, study and improvement, which will take into account immunosuppression in malignant gliomas and means of overcoming it, optimization in terms of target antigen selection, cell preparation and integration of dendritic vaccines into other treatment regimens.
Literature
5.
go back to reference Rynda AYu, Olyushin VE, Rostovtsev DM, Zabrodskaya YM, Ulitin AYu, Papayan GV (2023) Intraoperative photodynamic therapy in complex treatment of malignant gliomas. Burdenko’s Journal of Neurosurgery = Zhurnal Voprosy neirokhirurgii imeni N. N Burdenko 87(1):25–34 (In Russ.). https://doi.org/10.17116/neiro20238701125CrossRef Rynda AYu, Olyushin VE, Rostovtsev DM, Zabrodskaya YM, Ulitin AYu, Papayan GV (2023) Intraoperative photodynamic therapy in complex treatment of malignant gliomas. Burdenko’s Journal of Neurosurgery = Zhurnal Voprosy neirokhirurgii imeni N. N Burdenko 87(1):25–34 (In Russ.). https://​doi.​org/​10.​17116/​neiro20238701125​CrossRef
6.
go back to reference Rynda AYu, Olyushin VE, Rostovtsev DM, Zabrodskaya YM, Papayan GV (2022) Comparative analysis of 5-ALA and chlorin E6 fluorescence-guided navigation in malignant glioma Surgery. Pirogov Russian Journal of Surgery = Khirurgiya Zurnal Im N I Pirogova 15–14 (In Russ.). https://doi.org/10.17116/hirurgia20220115 Rynda AYu, Olyushin VE, Rostovtsev DM, Zabrodskaya YM, Papayan GV (2022) Comparative analysis of 5-ALA and chlorin E6 fluorescence-guided navigation in malignant glioma Surgery. Pirogov Russian Journal of Surgery = Khirurgiya Zurnal Im N I Pirogova 15–14 (In Russ.). https://​doi.​org/​10.​17116/​hirurgia20220115​
17.
22.
go back to reference Yu JS, Wheeler CJ, Zeltzer PM et al (2001) Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61:842–847PubMed Yu JS, Wheeler CJ, Zeltzer PM et al (2001) Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61:842–847PubMed
34.
Metadata
Title
Immunotherapy with autologous dendritic cells in the complex treatment of malignant gliomas - results
Authors
Artemii Yuryevich Rynda
Dmitrii M. Rostovthev
Yulia M. Zabrodskaya
Victor E. Olyushin
Publication date
16-01-2024
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2024
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-023-04559-1

Other articles of this Issue 2/2024

Journal of Neuro-Oncology 2/2024 Go to the issue